Intelligent Bio Solutions (INBS) Change in Receivables (2021 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly Change in Receivables of $244883.0 in Q1 2025, up 178.36% quarter-over-quarter from -$312498.0 in Q4 2024, and up 152.28% on a YoY basis from $97067.0 in Q1 2024.
Intelligent Bio Solutions (INBS) Change in Receivables (2021 - 2025) Analysis & Trends
Intelligent Bio Solutions' Change in Receivables history runs 5 years deep, the most recent figure standing at $244883.0 for Q1 2025.
- In Q1 2025, Change in Receivables rose 152.28% year-over-year to $244883.0; the TTM figure through Mar 2025 stood at $178326.0 (up 179.28% YoY), while the FY2023 annual figure was $293861.0, up 116.07% from the prior year.
- Change in Receivables was $244883.0 for Q1 2025 at Intelligent Bio Solutions, up from -$312498.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $674984.0 in Q4 2021 to a low of -$2.5 million in Q3 2021.
- Historically, Change in Receivables has averaged -$115644.2 across 5 years, with a median of $47439.5 in 2023.
- The sharpest annual moves came in 2023 and 2024: Change in Receivables plunged 167.92% in 2023, then soared 1971.71% in 2024.
- A 5-year view of Change in Receivables shows it stood at $674984.0 in 2021, then tumbled by 33.54% to $448567.0 in 2022, then tumbled by 167.92% to -$304676.0 in 2023, then declined by 2.57% to -$312498.0 in 2024, then jumped by 178.36% to $244883.0 in 2025.
- The last three Change in Receivables figures came in at $244883.0 (Q1 2025), -$312498.0 (Q4 2024), and $148874.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 244,883.00 |
| Mar 31, 2025 | 244,883.00 |
| Dec 31, 2024 | -312,498.00 |
| Dec 31, 2024 | -312,498.00 |
| Sep 30, 2024 | 148,874.00 |
| Sep 30, 2024 | 148,874.00 |
| Mar 31, 2024 | 97,067.00 |
| Mar 31, 2024 | 97,067.00 |
| Dec 31, 2023 | -304,676.00 |
| Dec 31, 2023 | -304,676.00 |
| Sep 30, 2023 | 273,649.00 |
| Sep 30, 2023 | 273,649.00 |
| Jun 30, 2023 | -2,188.00 |
| Jun 30, 2023 | -2,188.00 |
| Mar 31, 2023 | -5,186.00 |
| Mar 31, 2023 | -5,186.00 |
| Dec 31, 2022 | 448,567.00 |
| Dec 31, 2022 | 448,567.00 |
| Sep 30, 2022 | -147,332.00 |
| Sep 30, 2022 | -147,332.00 |